Published in Cancer Weekly, April 6th, 1998
In vitro studies with this antibody indicated its potential for high specificity for human lymphoma cells. It is as a result of this antibody binding potential that it was thought that the radiolabeled form of the antibody would bind to the tumor after injection and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.